Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
about
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell LymphomaIntravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Placental gene transfer: transgene screening in mice for trophic effects on the placenta.The phenotype of the human materno-fetal endothelial barrier: molecular occupancy of paracellular junctions dictate permeability and angiogenic plasticity.The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Effects of vascular endothelial growth factor 165 on bone tissue engineeringTargeting the Tie2/Tek receptor in astrocytomas.Wound healing characteristics of ICAM-1 null mice devoid of all isoforms of ICAM-1.Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.Cell and molecular mechanisms of insulin-induced angiogenesis.Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.Endothelial-Specific EphA4 Negatively Regulates Native Pial Collateral Formation and Re-Perfusion following Hindlimb Ischemia.Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healingIntussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling.Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis.Curcumin, a potential therapeutic candidate for retinal diseases.Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer.Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes MellitusBone marrow micro-environment is a crucial player for myelomagenesis and disease progression.Multi-chromatic control of mammalian gene expression and signaling.Synthetic two-way communication between mammalian cells.Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.Role of Ang1 and its interaction with VEGF-A in astrocytomas.Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions.A glycan-based approach to therapeutic angiogenesisTrehalose lyophilized platelets for wound healing.Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis.Gene expression in human ovarian tissue after xenografting.An Engineered Optogenetic Switch for Spatiotemporal Control of Gene Expression, Cell Differentiation, and Tissue Morphogenesis.Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia.Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium.Angiopoietin-1 for myocardial angiogenesis: a comparison between delivery strategies.Angiopoietin-1 mediates inhibition of hypertension-induced release of angiopoietin-2 from endothelial cells.Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.Angiogenesis in the human corpus luteum.
P2860
Q28071331-64EE247C-0A0A-45DA-B613-BDFB6F264764Q30681823-52F945DF-DF47-43F1-A877-AB086DF0ACD2Q33556657-3CBCB494-91FB-4F64-B9DD-C7224BA677B8Q33914452-1D6A2ECD-ED81-4C5F-AA83-658664845FC6Q34774016-D408C4F9-FB83-4DD0-AEC9-96EB128DDAE1Q35065245-09851EA7-5A9D-40FA-9084-14D2D97E744EQ35077816-D9BFE233-A699-4AE4-B6C1-845B6A7EBA5FQ35083402-57826981-A501-4ACB-821C-ADF5452FC467Q35376606-F865ECD8-0631-4DFB-8A45-5C057C2B38EDQ35541707-22DEBC11-2DFB-4E62-B876-CC2D9CCAF9F6Q35889110-2A6A27A5-6197-4890-B53D-91531EE4D3BCQ36011832-D09602A9-6497-4BCC-A11E-EBFFB5830890Q36088342-04580076-C732-4C0E-9FAA-3960ED8A4FE5Q36673673-F0E1C2AB-5337-4A19-B445-CFA6EC4E16CCQ37385888-2CFC76D3-BC5B-4FE9-B5DC-6DDEB14B9B51Q37610084-A10FF595-F851-4B60-A4E5-2385E7472F85Q38082487-ADCFA3F6-F2B1-4C14-BD33-CAB05A5CA89AQ38443447-A3AAB944-D493-488A-B75F-EC543BBCD1DEQ38928508-1185B586-66DF-46D5-A3D5-389027587753Q39093915-3C991A81-7FAE-4B99-B130-CDB9AD0C0C06Q39428565-F50A6D43-C7C1-4379-86BE-CFD42471E6B6Q39551932-4842B48F-6ECE-4AC7-BE59-7C1CE5936F9AQ39962482-0D71EF72-D659-4FB1-B2E4-09E5012095BAQ40510010-5C25ADFA-8047-4D70-8B35-D416CA0074D5Q40701859-413868A4-66F3-4F4E-A98D-5D3C0211F58BQ41200344-0A8B69ED-A7F5-42B0-801A-1934F0C06B55Q42164206-830793CA-BDA0-4ED7-8EF4-E31D30522794Q42176947-FBBA566F-7127-4698-9319-5727FC51C56FQ44550685-248E83FF-DEF0-4611-AB75-E4CBAF241DC3Q45200592-8BC899D6-04B5-4DC3-961E-3044850789EEQ45870616-77D5DC30-E75A-4D2E-AC9C-64F315FFCDD1Q48567815-29FDD5C6-2196-412D-8E5D-D772E214E31AQ49263652-E9E8782A-C5C5-4F8E-A924-043B92EDC3BEQ50687785-062055E7-537E-48F4-A4B4-EA41976585DDQ51772632-5D4272E4-BBB2-4232-8B7F-8E4438738899Q54170072-AD413A9D-A1D1-4794-8C68-E5DAD9F0B1F7Q54600065-92E08CC8-49F9-4BF2-9359-749DB926368AQ55092843-19293DE3-E285-4A51-ACE2-32A671517F97
P2860
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@ast
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@en
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@nl
type
label
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@ast
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@en
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@nl
prefLabel
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@ast
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@en
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@nl
P2860
P1433
P1476
Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.
@en
P2093
Gavin Thurston
P2860
P304
P356
10.1046/J.1469-7580.2002.00061.X
P577
2002-06-01T00:00:00Z